A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects (Q98945586)
Jump to navigation
Jump to search
clinical trial
- GRAd-COV2 Vaccine Against COVID-19
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects |
clinical trial |
|
Statements
A Phase 1, Dosage-Escalation Study to Assess the Safety and Immunogenicity of a COVID-19 Vaccine GRAd-COV2 in Healthy Adults and Elderly Subjects (English)
0 references
10 August 2020
0 references
31 July 2021
0 references
90
0 references